Ibrutinib reduces obinutuzumab infusion-related reactions in patients with chronic lymphocytic leukemia and is associated with changes in plasma cytokine levels

被引：11
|
作者：
Lujan, Juliana Velez [1 ]
Lengerke-Diaz, Paula A. [2 ]
Jacobs, Chaja [1 ]
Moreno-Cortes, Eider F. [2 ]
Ramirez-Segura, Cesar A. [2 ]
Choi, Michael Y. [1 ]
McCarthy, Colin [1 ]
Heinen, Alaina [1 ]
Kipps, Thomas J. [1 ]
Castro, Januario E. [1 ,2 ]
机构：
[1] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA
[2] Mayo Clin, Scottsdale, AZ USA
来源：
HAEMATOLOGICA | 2020年 / 105卷 / 01期
关键词：
MONOCLONAL-ANTIBODY; CLL PATIENTS; CHLORAMBUCIL; RELEASE;
D O I：
10.3324/haematol.2018.212597
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E22 / E25
页数：4
相关论文
共 50 条
  • [1] Managing Infusion-Related Reactions for Patients With Chronic Lymphocytic Leukemia Receiving Obinutuzumab
    Dawson, Keith
    Moran, Mollie
    Guindon, Kathleen
    Wan, Hui
    [J]. CLINICAL JOURNAL OF ONCOLOGY NURSING, 2016, 20 (02) : E41 - E48
  • [2] Assessment of Measures to Reduce Infusion-Related Reactions in Patients with Chronic Lymphocytic Leukemia Treated with Obinutuzumab in the GREEN Study
    Bosch, Francesc
    Foa, Robin
    Cortelezzi, Agostino
    Kisro, Jens
    Leblond, Veronique
    Tumyan, Gayane
    Gresko, Ekaterina
    Robson, Susan
    Stilgenbauer, Stephan
    [J]. BLOOD, 2016, 128 (22)
  • [3] Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study
    Richard Greil
    Alessandra Tedeschi
    Carol Moreno
    Bertrand Anz
    Loree Larratt
    Martin Simkovic
    Devinder Gill
    John G. Gribben
    Ian W. Flinn
    Zhengyuan Wang
    Leo W. K. Cheung
    Aaron N. Nguyen
    Cathy Zhou
    Lori Styles
    Fatih Demirkan
    [J]. Annals of Hematology, 2021, 100 : 1733 - 1742
  • [4] Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study
    Greil, Richard
    Tedeschi, Alessandra
    Moreno, Carol
    Anz, Bertrand
    Larratt, Loree
    Simkovic, Martin
    Gill, Devinder
    Gribben, John G.
    Flinn, Ian W.
    Wang, Zhengyuan
    Cheung, Leo W. K.
    Nguyen, Aaron N.
    Zhou, Cathy
    Styles, Lori
    Demirkan, Fatih
    [J]. ANNALS OF HEMATOLOGY, 2021, 100 (07) : 1733 - 1742
  • [5] RITUXIMAB INFUSION-RELATED TOXICITY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    Simkovic, M.
    Motyckova, M.
    Belada, D.
    Maly, J.
    Smolej, L.
    [J]. HAEMATOLOGICA, 2012, 97 : 525 - 525
  • [6] Cytokine release in patients with CLL treated with obinutuzumab and possible relationship with infusion-related reactions
    Freeman, Ciara L.
    Morschhauser, Franck
    Sehn, Laurie
    Dixon, Mark
    Houghton, Richard
    Lamy, Thierry
    Fingerle-Rowson, Guenter
    Wassner-Fritsch, Elisabeth
    Gribben, John G.
    Hallek, Michael
    Salles, Gilles
    Cartron, Guillaume
    [J]. BLOOD, 2015, 126 (24) : 2646 - 2649
  • [7] Pattern of Cytokine Release in Patients with Chronic Lymphocytic Leukemia Treated with Obinutuzumab and Possible Relationship with Development of Infusion Related Reactions (IRR)
    Freeman, Ciara Louise
    Morschhauser, Franck
    Sehn, Laurie H.
    Dixon, Mark
    Houghton, Richard
    Lamy, Thierry
    Fingerle-Rowson, Gunter
    Wassner-Fritsch, Elisabeth
    Hallek, Michael
    Salles, Gilles
    Cartron, Guillaume
    [J]. BLOOD, 2014, 124 (21)
  • [8] BUDGET IMPACT ANALYSIS OF OBINUTUZUMAB AND IBRUTINIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN RUSSIA
    Derkach, E., V
    Rebrova, O. Y.
    Fedyaeva, V. K.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A582 - A582
  • [9] Pattern of cytokine release in patients with chronic lymphocytic leukaemia treated with obinutuzumab and possible relationship with development of infusion related reactions (IRR)
    Freeman, C.
    Morschhauser, F.
    Sehn, L.
    Dixon, M.
    Houghton, R.
    Lamy, T.
    Fingerle-Rowson, G.
    Wassner-Fritsch, E.
    Hallek, M.
    Salles, G.
    Cartron, G.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 : 64 - 64
  • [10] Ibrutinib, idelalisib and obinutuzumab for the treatment of patients with chronic lymphocytic leukemia: three new arrows aiming at the target
    Morabito, Fortunato
    Gentile, Massimo
    Seymour, John F.
    Polliack, Aaron
    [J]. LEUKEMIA & LYMPHOMA, 2015, 56 (12) : 3250 - 3256
12345